drugset / Trial / NCT00122096

Perioperative Inflammation and Cyclooxygenase 2 (COX-2)

NCT00122096

Phase 4 Completed 30 enrolled University of Washington Pfizer · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Surgery initiates a complex cascade of events involving the release of chemical compounds from nerve endings and damaged tissue which leads to an inflammatory and pain response. The purpose of this investigation is to measure various chemical mediators in the blood and cerebrospinal fluid, and to test the hypothesis that they will be decreased in patients treated with a COX-2 inhibitor.

Timeline

Start
2002-11
Primary completion
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject valdecoxib Small molecule 40 mg

Indications

No indication recorded.